Wed, 17 Sep 2025

Wed, 17 Sep 2025 Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

Eli Lilly said orforglipron was better at lowering blood sugar levels than Novo Nordisk's oral semaglutide, and helped patients lose more weight.

  >>


Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025